A carregar...
Investigational drugs for the treatment of AD: what can we learn from negative trials?
Given the level of interest and activity in the race to find a treatment for Alzheimer's disease, it is expected that a reasonably safe and effective drug will be identified within the next decade. It may be worthwhile to pause periodically during the course of this race to take stock of what w...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3226276/ https://ncbi.nlm.nih.gov/pubmed/21539725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/alzrt73 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|